AP3000A - Slow release pharmaceutical composition made of microparticles - Google Patents

Slow release pharmaceutical composition made of microparticles

Info

Publication number
AP3000A
AP3000A AP2009005088A AP2009005088A AP3000A AP 3000 A AP3000 A AP 3000A AP 2009005088 A AP2009005088 A AP 2009005088A AP 2009005088 A AP2009005088 A AP 2009005088A AP 3000 A AP3000 A AP 3000A
Authority
AP
ARIPO
Prior art keywords
microparticles
pharmaceutical composition
slow release
release pharmaceutical
composition made
Prior art date
Application number
AP2009005088A
Other languages
English (en)
Other versions
AP2009005088A0 (en
Inventor
Bertrand Ducrey
Patrick Garrouste
Catherine Curdy
Original Assignee
Debiopharm Res & Mfg Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032512&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP3000(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Res & Mfg Sa filed Critical Debiopharm Res & Mfg Sa
Publication of AP2009005088A0 publication Critical patent/AP2009005088A0/en
Application granted granted Critical
Publication of AP3000A publication Critical patent/AP3000A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AP2009005088A 2007-06-06 2008-06-06 Slow release pharmaceutical composition made of microparticles AP3000A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07109767 2007-06-06
IB2007054372 2007-10-27

Publications (2)

Publication Number Publication Date
AP2009005088A0 AP2009005088A0 (en) 2009-12-31
AP3000A true AP3000A (en) 2014-10-31

Family

ID=40032512

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2009005088A AP3000A (en) 2007-06-06 2008-06-06 Slow release pharmaceutical composition made of microparticles

Country Status (32)

Country Link
US (4) US10166181B2 (pl)
EP (3) EP2500014B2 (pl)
JP (1) JP5419169B2 (pl)
KR (1) KR101631475B1 (pl)
CN (1) CN101677959B (pl)
AP (1) AP3000A (pl)
AU (1) AU2008259411B2 (pl)
BR (1) BRPI0812250B8 (pl)
CA (1) CA2688478C (pl)
CO (1) CO6251234A2 (pl)
CY (2) CY1118434T1 (pl)
DK (2) DK2500014T4 (pl)
EA (1) EA019284B1 (pl)
ES (2) ES2694401T5 (pl)
FI (1) FI2500014T4 (pl)
HR (2) HRP20161785T1 (pl)
HU (2) HUE040391T2 (pl)
IL (1) IL202501A (pl)
LT (2) LT2500014T (pl)
MA (1) MA31422B1 (pl)
ME (1) ME00959B (pl)
MX (1) MX2009012856A (pl)
MY (1) MY150450A (pl)
NZ (1) NZ582423A (pl)
PL (2) PL2500014T5 (pl)
PT (2) PT2500014T (pl)
RS (2) RS58248B1 (pl)
SI (2) SI2164467T1 (pl)
TN (1) TN2009000476A1 (pl)
UA (1) UA99830C2 (pl)
WO (1) WO2008149320A2 (pl)
ZA (1) ZA200907940B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI2500014T4 (fi) 2007-06-06 2025-04-08 Debiopharm Int Sa Mikropartikkeleista valmistettu hitaasti vapauttava farmaseuttinen koostumus
PT105270B (pt) 2010-08-26 2012-05-31 Domino Ind Ceramicas S A Camada de sílica com libertação lenta de fragrância, telha cerâmica e respectivo processo de produção
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN105797134B (zh) * 2016-03-29 2019-06-14 浙江圣兆药物科技股份有限公司 一种难溶亮丙瑞林缓释制剂
WO2018083633A1 (en) 2016-11-02 2018-05-11 Debiopharm International, S.A. Methods for improving anti-cd37 immunoconjugate therapy
KR102402639B1 (ko) 2017-11-24 2022-05-26 삼성전자주식회사 전자 장치 및 그의 통신 방법
CN111000798B (zh) * 2019-12-26 2021-11-23 四川恒博生物科技有限公司 一种采用原位凝胶技术的犬用非手术去势注射液
IT202000017191A1 (it) 2020-07-15 2022-01-15 Xbrane Biopharma Ab Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale
WO2025017533A1 (en) 2023-07-20 2025-01-23 Ferring B.V. Extended release drug-loaded microparticles
AR134273A1 (es) * 2023-11-08 2025-12-17 Debiopharm Int Sa Triptorelina 12 meses
CN121401211A (zh) * 2024-02-29 2026-01-27 珠海市华海康医药科技有限责任公司 一种双羟萘酸盐药物缓释微球及其制备方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5134122A (en) * 1989-07-28 1992-07-28 Debiopharm S.A. Method for preparing a pharmaceutical composition in the form of microparticles
GB2257909A (en) * 1991-07-22 1993-01-27 Debio Rech Pharma Sa Preparation of controlled release peptide compositions
US5192741A (en) * 1987-09-21 1993-03-09 Debiopharm S.A. Sustained and controlled release of water insoluble polypeptides
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
US5540937A (en) * 1992-07-27 1996-07-30 Rhone Merieux Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
US20020013273A1 (en) * 1997-11-07 2002-01-31 Bret Shirley Method for producing sustained-release formulations
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
WO2004096259A1 (en) * 2003-04-30 2004-11-11 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190833B1 (en) 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
MY107937A (en) 1990-02-13 1996-06-29 Takeda Chemical Industries Ltd Prolonged release microcapsules.
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
ATE223702T1 (de) * 1993-10-22 2002-09-15 Genentech Inc Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
MY118835A (en) * 1997-04-18 2005-01-31 Ipsen Pharma Biotech Sustained release compositions and the process for their preparation
TW200800298A (en) * 2000-01-27 2008-01-01 Zentaris Ag Compressed microparticles for dry injection
WO2003030870A1 (fr) * 2001-10-10 2003-04-17 Pierre Fabre Medicament Microspheres biodegradables a liberation prolongee et leur procede de preparation
KR100466637B1 (ko) * 2003-06-26 2005-01-13 주식회사 펩트론 서방성 미립구의 혼합 제형을 연속한 단일 공정으로제조하는 방법
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
EP1968549B1 (en) 2005-12-22 2014-05-14 Novartis AG Sustained release formulation comprising octreotide and two or more polylactide-co-glycolide polymers
FI2500014T4 (fi) 2007-06-06 2025-04-08 Debiopharm Int Sa Mikropartikkeleista valmistettu hitaasti vapauttava farmaseuttinen koostumus

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192741A (en) * 1987-09-21 1993-03-09 Debiopharm S.A. Sustained and controlled release of water insoluble polypeptides
US5134122A (en) * 1989-07-28 1992-07-28 Debiopharm S.A. Method for preparing a pharmaceutical composition in the form of microparticles
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
GB2257909A (en) * 1991-07-22 1993-01-27 Debio Rech Pharma Sa Preparation of controlled release peptide compositions
US5540937A (en) * 1992-07-27 1996-07-30 Rhone Merieux Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
US20020013273A1 (en) * 1997-11-07 2002-01-31 Bret Shirley Method for producing sustained-release formulations
US20040170665A1 (en) * 2000-06-02 2004-09-02 Allergan, Inc. Intravitreal botulinum toxin implant
WO2004096259A1 (en) * 2003-04-30 2004-11-11 Debiopharm S.A. Methods and compositions using gonadotropin hormone releasing hormone

Also Published As

Publication number Publication date
ME00959B (me) 2012-06-20
DK2500014T4 (da) 2025-04-14
EA019284B1 (ru) 2014-02-28
UA99830C2 (uk) 2012-10-10
ES2694401T3 (es) 2018-12-20
LT2500014T (lt) 2019-01-25
EP2500014A2 (en) 2012-09-19
BRPI0812250B1 (pt) 2020-03-03
HUE031550T2 (en) 2017-07-28
US20110052717A1 (en) 2011-03-03
DK2164467T3 (en) 2017-01-30
TN2009000476A1 (en) 2011-03-31
EP2500014B2 (en) 2025-02-19
KR101631475B1 (ko) 2016-06-20
RS55591B1 (sr) 2017-06-30
HRP20181854T4 (hr) 2025-05-09
JP2010529106A (ja) 2010-08-26
EP2500014B1 (en) 2018-08-08
MY150450A (en) 2014-01-30
RS58248B1 (sr) 2019-03-29
US10166181B2 (en) 2019-01-01
CO6251234A2 (es) 2011-02-21
SI2500014T1 (sl) 2019-02-28
AP2009005088A0 (en) 2009-12-31
ZA200907940B (en) 2010-08-25
ES2694401T5 (es) 2025-05-16
CY1120891T1 (el) 2019-12-11
US20250205148A1 (en) 2025-06-26
BRPI0812250A2 (pt) 2014-12-23
WO2008149320A2 (en) 2008-12-11
IL202501A0 (en) 2010-06-30
HRP20181854T1 (hr) 2019-02-08
EP2164467A2 (en) 2010-03-24
EP2164467B1 (en) 2016-12-14
AU2008259411B2 (en) 2013-10-17
JP5419169B2 (ja) 2014-02-19
EP2500014A3 (en) 2012-11-07
CA2688478C (en) 2015-10-27
SI2500014T2 (sl) 2025-05-30
MA31422B1 (fr) 2010-06-01
ES2611020T3 (es) 2017-05-04
KR20100023950A (ko) 2010-03-04
IL202501A (en) 2015-11-30
WO2008149320A3 (en) 2009-02-05
MX2009012856A (es) 2009-12-15
LT2164467T (lt) 2017-01-25
HUE040391T2 (hu) 2019-03-28
BRPI0812250B8 (pt) 2021-05-25
HK1141737A1 (en) 2010-11-19
DK2500014T3 (en) 2018-12-03
PT2164467T (pt) 2017-01-13
CA2688478A1 (en) 2008-12-11
CN101677959B (zh) 2014-02-26
NZ582423A (en) 2011-10-28
US20230082575A1 (en) 2023-03-16
US20190192423A1 (en) 2019-06-27
PL2164467T3 (pl) 2017-07-31
PT2500014T (pt) 2018-11-21
SI2164467T1 (sl) 2017-05-31
FI2500014T4 (fi) 2025-04-08
EP3431077A1 (en) 2019-01-23
PL2500014T5 (pl) 2025-05-05
AU2008259411A1 (en) 2008-12-11
CY1118434T1 (el) 2017-06-28
PL2500014T3 (pl) 2019-04-30
CN101677959A (zh) 2010-03-24
EA200971132A1 (ru) 2010-04-30
HRP20161785T1 (hr) 2017-03-10

Similar Documents

Publication Publication Date Title
AP3000A (en) Slow release pharmaceutical composition made of microparticles
PT2345410T (pt) Composição farmacêutica para libertação modificada
EP2308473A4 (en) PHARMACEUTICAL COMPOSITION CONTAINING MICROPARTICLES WITH SURFACE COATING
EP2240173A4 (en) PHARMACEUTICAL COMPOSITION OF DULOXETINE WITH DELAYED RELEASE
PT2251006T (pt) Micropartículas e suas composições farmacêuticas
AP2920A (en) Anti-malarial pharmaceutical composition
ZA201102715B (en) Solid pharmaceutical composition
ZA201100871B (en) Solid pharmaceutical composition
GB0902648D0 (en) Pharmaceutical compounds and compositions
PL2277511T3 (pl) Kompozycje farmaceutyczne lewetiracetamu o przedłużonym uwalnianiu
GB0908317D0 (en) Pharmaceutical compounds and compositions
IL178378A0 (en) Extended release pharmaceutical compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions